From Simulation to Regulation? FDA Tries Out New Approach to Policy Development

article image

CDRH is building a digital simulation system to support rapid modeling of new regulatory paradigms for digital health and, potentially, the broader medtech arena.

New regulatory policies can originate from on-the-ground experiences of regulators, top-down political priorities, or stakeholder recommendations, but FDA is now trying a relatively new approach to policymaking: digital simulations. In a first for the agency, CDRH’s digital health team has created what it is calling the “Precertification Simulator,” an in silico tool for rapidly modeling out the impacts and risks of different regulatory paradigms to fine-tune the most effective approach.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: